Tabomedex focuses on the R&a;D of new drugs related to type 2 diabetes.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Boston
State: Massachusetts
Zip:
Country: United States
Tabomedex focuses on the R&a;D of new drugs related to type 2 diabetes. They mainly study the mechanism of action of MK2 and achieve the effect of controlling blood glucose level by inhibiting MK2, namely inhibiting the effect of downstream avtivating enzymes.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2016 | Series A | 3 | $5M |
JMCR Partners Viva BioInnovator Viva Ventures Biotech Fund JMCR Partners Viva BioInnovator Viva Ventures Biotech Fund |
8/2020 | Series A | - | 6/2017 | Series A | - | 8/2020 | Series A | - | 6/2017 | Series A | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|